Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1998
06/11/1998WO1998024925A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens
06/11/1998WO1998024924A1 Genetic modification of primate hemopoietic repopulating stem cells
06/11/1998WO1998024923A1 Inactivation of hiv co-receptors as therapy for hiv infection
06/11/1998WO1998024922A1 Insulin-like growth factor i (igf-i) expression system and methods of use
06/11/1998WO1998024921A1 Syndecan enhancer element and its use for targeting gene expression
06/11/1998WO1998024920A2 How to affect the chlorophyll biosynthesis in plants
06/11/1998WO1998024918A1 Gene trap construct for identification and isolation of genes
06/11/1998WO1998024916A1 Novel calpaines, production and use thereof
06/11/1998WO1998024915A1 Protein phosphatase 2a subunit polypeptide
06/11/1998WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998WO1998024913A2 Method and reagent for the treatment of a disease associated with interleukin-2 receptor gamma-chain expression
06/11/1998WO1998024912A2 Recombinant plague vaccine
06/11/1998WO1998024911A2 Mutants of streptococcal toxin a and methods of use
06/11/1998WO1998024910A2 Mutants of streptococcal toxin c and methods of use
06/11/1998WO1998024909A1 Chaperone fragments
06/11/1998WO1998024908A1 Human chemokine beta-13
06/11/1998WO1998024907A1 Novel protein with chemokine activity
06/11/1998WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents
06/11/1998WO1998024905A2 Secreted proteins and polynucleotides encoding them
06/11/1998WO1998024903A1 Isolation and use of erythroid differentiation and denucleation factors
06/11/1998WO1998024902A1 Adaptor protein frs2 and related products and methods
06/11/1998WO1998024901A1 Lung growth factor variant
06/11/1998WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998WO1998024899A1 IgA NEPHROPATHY-ASSOCIATED GENE
06/11/1998WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein
06/11/1998WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
06/11/1998WO1998024896A2 Muteins of obese protein
06/11/1998WO1998024895A1 Receptor belonging to the tnf/ngf receptor family
06/11/1998WO1998024893A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM
06/11/1998WO1998024892A1 Ve-cadherin promoter and its uses
06/11/1998WO1998024891A1 M. tuberculosis rna polymerase alpha subunit
06/11/1998WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods
06/11/1998WO1998024887A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
06/11/1998WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998WO1998024882A1 Methods of preserving prokaryotic cells and compositions obtained thereby
06/11/1998WO1998024881A1 Mutant ob receptors and nucleotides encoding them
06/11/1998WO1998024819A1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
06/11/1998WO1998024817A1 Novel dna, novel protein, and novel antibody
06/11/1998WO1998024813A2 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives
06/11/1998WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998WO1998024798A1 BIOSYNTHETIC GENE murI FROM $i(STREPTOCOCCUS PNEUMONIAE)
06/11/1998WO1998024797A1 Antisense inhibition of human adhesion molecules
06/11/1998WO1998024479A1 Adeno-associated viral vector-mediated delivery of dna to cells of the liver
06/11/1998WO1998024475A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
06/11/1998WO1998024473A1 Tissue fibrosis inhibitor
06/11/1998WO1998024454A1 Human trophoblast and choriocarcinoma inhibition
06/11/1998WO1998024300A1 Carotenoid-associated proteins useful for high carotenoid accumulation and production in plants and other organisms
06/11/1998WO1998024297A1 Hypersensitive response induced resistance in plants by seed treatment
06/11/1998WO1998018949A3 Plant cellulose synthase and promoter sequences
06/11/1998WO1998012910A3 Novel CREBa isoform
06/11/1998WO1998011246A3 ENDO-β-GALACTOSIDASE
06/11/1998WO1998006749A3 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
06/11/1998CA2722378A1 Human antibodies that bind tnf alpha
06/11/1998CA2689842A1 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
06/11/1998CA2298100A1 How to affect the chlorophyll biosynthesis in plants
06/11/1998CA2277580A1 Human chemokine beta-13
06/11/1998CA2274584A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens
06/11/1998CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
06/11/1998CA2274315A1 Detection of chromosomal abnormalities
06/11/1998CA2274309A1 Novel dna, novel protein, and novel antibody
06/11/1998CA2274304A1 Novel calpaines, production and use thereof
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998CA2274098A1 M. tuberculosis rna polymerase alpha subunit
06/11/1998CA2274095A1 Compositions and methods for administering pneumococcal dna
06/11/1998CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998CA2273845A1 Secreted proteins and polynucleotides encoding them
06/11/1998CA2273844A1 Biosynthetic gene muri from streptococcus pneumoniae
06/11/1998CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998CA2273822A1 Mutants of streptococcal toxin a and methods of use
06/11/1998CA2273203A1 Antisense inhibition of human adhesion molecules
06/11/1998CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
06/11/1998CA2273199A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
06/11/1998CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998CA2273192A1 Inactivation of hiv co-receptors as therapy for hiv infection
06/11/1998CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them
06/11/1998CA2273164A1 Mutant ob receptors and nucleotides encoding them
06/11/1998CA2272994A1 Ve-cadherin promoter and its uses
06/11/1998CA2272851A1 Syndecan enhancer element and its use for targeting gene expression
06/11/1998CA2272848A1 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
06/11/1998CA2272821A1 Methods of preserving prokaryotic cells and compositions obtained thereby
06/11/1998CA2271948A1 Male infertility y-deletion detection battery
06/11/1998CA2224334A1 Self-enhancing, pharmacologically controllable expression systems
06/11/1998CA2224131A1 Novel human 11 cb splice variant
06/10/1998EP0846776A2 Devices and methods for detecting multiple analytes in samples
06/10/1998EP0846772A1 Multifunctional ligand system for cell-specific transfer of nucleic acid
06/10/1998EP0846771A1 Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells
06/10/1998EP0846770A1 Method for the expression of foreign genes and vectors therefor
06/10/1998EP0846769A2 Biosynthetic gene murI from streptococcus pneumoniae
06/10/1998EP0846768A2 Esterase gene and its use
06/10/1998EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae
06/10/1998EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae
06/10/1998EP0846765A1 Cell proliferation inhibitor
06/10/1998EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family
06/10/1998EP0846763A2 A protein phosphatase 1 binding protein, R5
06/10/1998EP0846762A2 Novel V31 seven transmembrane receptors
06/10/1998EP0846761A1 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof
06/10/1998EP0846760A1 Production and use of anthelmintic agents and protective immunogens
06/10/1998EP0846759A1 Gene encoding protein having asymmetric hydrolase activity on 4-substituted-1,4-dihydropyridine derivatives and expression product of the same
06/10/1998EP0846702A2 Soluble recombinant Alpha 5 Beta 3 adhesion receptor
1 ... 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 ... 4023